1-5 of 5
Tae Won Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors

Tae Won Kim, Howard A. Burris, III, Maria J. de Miguel Luken, Michael J. Pishvaian, Yung-Jue Bang, Michael Gordon, Ahmad Awada, D. Ross Camidge, F. Stephen Hodi, Grant A. McArthur, Wilson H. Miller, Jr, Andres Cervantes, Laura Q. Chow, Alexander M. Lesokhin, Annemie Rutten, Mario Sznol, Deepali Rishipathak, Shang-Chiung Chen, Eric Stefanich, Tony Pourmohamad, Maria Anderson, Jeong Kim, Mahrukh Huseni, Ina Rhee, Lillian L. Siu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (16): 3452–3463.
https://doi.org/10.1158/1078-0432.CCR-21-4020
Published: 15 August 2022
View article titled, First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Open the PDF for First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study

Marc Peeters, Timothy Price, Michael Boedigheimer, Tae Won Kim, Paul Ruff, Peter Gibbs, Anne Thomas, Gaston Demonty, Kristina Hool, Agnes Ang
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1216–1225.
https://doi.org/10.1158/1078-0432.CCR-18-2072
Published: 15 February 2019
View article titled, Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study
Open the PDF for Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study in another window
Includes: Supplementary data
Journal Articles

Impact of Emergent Circulating Tumor DNA RAS Mutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal Cancer

Tae Won Kim, Marc Peeters, Anne Thomas, Peter Gibbs, Kristina Hool, Jianqi Zhang, Agnes Lee Ang, Bruce Allen Bach, Timothy Price
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (22): 5602–5609.
https://doi.org/10.1158/1078-0432.CCR-17-3377
Published: 15 November 2018
View article titled, Impact of Emergent Circulating Tumor DNA <em>RAS</em> Mutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal Cancer
Open the PDF for Impact of Emergent Circulating Tumor DNA <em>RAS</em> Mutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Proton pump inhibitor beyond acid suppressions: Angiogenesis regulation and anti-inflammation

Ki-Baik Hahm, Tae won Kim, Yong Woon Shin, Don Haeng Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15_Supplement): A10.
Published: 15 August 2014
View article titled, Proton pump inhibitor beyond acid suppressions: Angiogenesis regulation and anti-inflammation
Journal Articles

Prognostic Significance of c-kit Mutation in Localized Gastrointestinal Stromal Tumors

Tae Won Kim, Hyoungnam Lee, Yoon-Koo Kang, Mi Sun Choe, Min-Hee Ryu, Heung Moon Chang, Jung Sun Kim, Jeong Hwan Yook, Byung Sik Kim, Jung Shin Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (9): 3076–3081.
https://doi.org/10.1158/1078-0432.CCR-03-0581
Published: 06 May 2004
View article titled, Prognostic Significance of <em>c-kit</em> Mutation in Localized Gastrointestinal Stromal Tumors
Open the PDF for Prognostic Significance of <em>c-kit</em> Mutation in Localized Gastrointestinal Stromal Tumors in another window